Chembio Diagnostics, Inc. (CEMI) Receives Up To $13.2M by U.S. Government for Rapid POC Zika Test and Related Products
Chembio Diagnostics, Inc. (NASDAQ: CEMI) has received a contract for up to $13.2 million in funding by the U.S government (http://nnw.fm/Tfx2x). This includes funding from the U.S. Department of Health and Human Services (HHS), Biomedical Advance Research and Development Authority (BARDA), and the Office of the Assistant Secretary for Preparedness and Response. The new contract is for the development and sale of Chembio’s quick point-of-care (POC) Zika tests and its other Zika products. “We are very happy to receive this BARDA contract as it will allow the company to further develop the DPP® Zika IgM/IgG Assays, complete key clinical trials,…







